REMAL is a compound containing 40mg of dihydroartemisinin and 320mg of Piperaquine Phosphate and necessary excipients in each tablet, REMAL has a rapid and powerful plasma schizonticide with rapid symptom control and effectiveness for multi-drug resistant falciparum malaria, and remarkable inhibitory effect on falciparum gametocyte thus minimizing the malaria transmissibility, Pharmacodynamic studies on mice and monkeys demonstrated that two ingredients of REMAL have obvious synergistic effect. REMAL is used in the treatment of all kinds of malaria including chloroquine-resistant P.falciparium and P.vivax malaria.
1. Those who are allergic to any of the two active ingredients are prohibited to use.
2. Those with severe liver or kidney diseases, haematophathy (e.g Leucopenia or thrombocytopenia) porphyria are prohibited to use.
There are no reviews yet.